🦊/Companies

Heligenics

Las Vegas, US · Founded 2019 · Nevada corporation

Find your way into Heligenics

Heligenics is a genomics and cell biology company that develops assays and platforms for drug screening and genetic analysis. The company serves pharmaceutical and biotech organizations conducting research in functional genomics and cellular engineering.

Founders & leadership

Heligenics was founded in 2019 by Martin Schiller, Ph.D..

MS
Martin Schiller, Ph.D.Founder & CEO
LJ
Lawrence John LoomisChief Operating Office & Corporate Secretary
MS
Martin SchillerNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$6M disclosed across 3 rounds · 2020–2024

$2.6MraisedJan 2025 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin SchillerExecutive Officer
Offering amount
$2.6M
Amount sold
$2.6M
Minimum investment
$10K
First sale
Aug 2024
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.2MraisedAug 2022 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin R SchillerExecutive Officer
Offering amount
$2.2M
Amount sold
$2.2M
Minimum investment
$10K
First sale
Jun 2022
Incorporated
Corporation, Nevada, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.2MraisedDec 2020 · 39 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lawrence John LoomisExecutive Officer, Director
Offering amount
$2.4M
Amount sold
$1.2M
Minimum investment
$2K
First sale
Mar 2020
Incorporated
Corporation, Nevada, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap

Companies competing with Heligenics for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2023$398.5K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

What does Heligenics do?
Heligenics is a genomics and cell biology company that develops assays and platforms for drug screening and genetic analysis. The company serves pharmaceutical and biotech organizations conducting research in functional genomics and cellular engineering.
Who founded Heligenics?
Heligenics was founded by Martin Schiller, Ph.D. in 2019.
How much funding has Heligenics raised?
Heligenics has disclosed $6M raised across 3 rounds.
Where is Heligenics headquartered?
Heligenics is headquartered in Las Vegas, US.